MyAverix Finance
SHG · Healthcare
Shandong Kexing Bioproducts Co. Ltd. A (688136)
Biotechnology
Shandong Kexing Bioproducts Co. Ltd. A (688136) is listed on SHG in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $5.47B, P/E ratio is 18.00, net margin is 10.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 688136
Shandong Kexing Bioproducts Co. Ltd. A (688136) — FAQ
What is Shandong Kexing Bioproducts Co. Ltd. A's market cap?
Shandong Kexing Bioproducts Co. Ltd. A (688136) has a reported market cap of $5.47B (data as of 2026-03-29).
What is 688136's P/E ratio?
The price-to-earnings (P/E) ratio for Shandong Kexing Bioproducts Co. Ltd. A (688136) is 18.00 (data as of 2026-03-29).
Does Shandong Kexing Bioproducts Co. Ltd. A pay a dividend?
Dividend yield is not available in the current snapshot for Shandong Kexing Bioproducts Co. Ltd. A (688136). Check the MyAverix Finance app for the latest dividend data.
What sector is Shandong Kexing Bioproducts Co. Ltd. A in?
Shandong Kexing Bioproducts Co. Ltd. A (688136) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 688136 listed on?
688136 is listed on SHG.
What is Shandong Kexing Bioproducts Co. Ltd. A's net margin?
Shandong Kexing Bioproducts Co. Ltd. A (688136) reports a net margin of 10.4% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.